NSC |
Compound |
Enrichment |
Correlation |
NSC 715778 |
Null |
0.0385613993886001 |
0.12231416 |
NSC 71669 |
Null |
0.0385613993886001 |
0.12965427 |
NSC 716951 |
Null |
0.0385613993886001 |
0.15756328 |
NSC 720299 |
Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane |
0.0385613993886001 |
0.38633646 |
NSC 720386 |
Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane |
0.0385613993886001 |
0.1655925 |
NSC 727087 |
16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.0385613993886001 |
0.067277948 |
NSC 72961 |
8-Azadenosine |
0.0385613993886001 |
0.30403923 |
NSC 730868 |
(+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one |
0.0385613993886001 |
0.31585821 |
NSC 732178 |
Null |
0.0385613993886001 |
0.016887083 |
NSC 740 |
Methotrexate |
0.0385613993886001 |
0.26630422 |